<DOC>
	<DOCNO>NCT01562561</DOCNO>
	<brief_summary>This trial conduct Asia South Africa . The aim trial compare efficacy safety repaglinide plus insulin NPH ( insulin Neutral Protamine Hagedorn ) insulin NPH alone subject type 2 diabetes inadequately control repaglinide .</brief_summary>
	<brief_title>Efficacy Safety Repaglinide Combined With Insulin NPH Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes HbA1c ( glycosylated haemoglobin ) : 713 % ( inclusive ) BMI ( body mass index ) maximum 35 kg/m^2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>